Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1994 May;69(5):799–801. doi: 10.1038/bjc.1994.157

Breast cancer: the obesity connection.

B A Stoll
PMCID: PMC1968889  PMID: 8180007

Full text

PDF
799

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albanes D. Caloric intake, body weight, and cancer: a review. Nutr Cancer. 1987;9(4):199–217. doi: 10.1080/01635588709513929. [DOI] [PubMed] [Google Scholar]
  2. Ballard-Barbash R., Schatzkin A., Carter C. L., Kannel W. B., Kreger B. E., D'Agostino R. B., Splansky G. L., Anderson K. M., Helsel W. E. Body fat distribution and breast cancer in the Framingham Study. J Natl Cancer Inst. 1990 Feb 21;82(4):286–290. doi: 10.1093/jnci/82.4.286. [DOI] [PubMed] [Google Scholar]
  3. Berstein L. M. Increased risk of breast cancer in women with central obesity: additional considerations. J Natl Cancer Inst. 1990 Dec 19;82(24):1943–1944. doi: 10.1093/jnci/82.24.1943-a. [DOI] [PubMed] [Google Scholar]
  4. Björntorp P. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev. 1988 Sep;4(6):615–622. doi: 10.1002/dmr.5610040607. [DOI] [PubMed] [Google Scholar]
  5. Bruning P. F., Bonfrèr J. M., van Noord P. A., Hart A. A., de Jong-Bakker M., Nooijen W. J. Insulin resistance and breast-cancer risk. Int J Cancer. 1992 Oct 21;52(4):511–516. doi: 10.1002/ijc.2910520402. [DOI] [PubMed] [Google Scholar]
  6. Bulbrook R. D. Geographical variation in endocrine function and its relation to breast cancer incidence: some general considerations. Breast Cancer Res Treat. 1991 May;18 (Suppl 1):S37–S40. doi: 10.1007/BF02633525. [DOI] [PubMed] [Google Scholar]
  7. Caro J. F. Clinical review 26: Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab. 1991 Oct;73(4):691–695. doi: 10.1210/jcem-73-4-691. [DOI] [PubMed] [Google Scholar]
  8. Conover C. A., Lee P. D., Kanaley J. A., Clarkson J. T., Jensen M. D. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab. 1992 Jun;74(6):1355–1360. doi: 10.1210/jcem.74.6.1375600. [DOI] [PubMed] [Google Scholar]
  9. Cullen K. J., Smith H. S., Hill S., Rosen N., Lippman M. E. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res. 1991 Sep 15;51(18):4978–4985. [PubMed] [Google Scholar]
  10. De Waard F. Endocrine aspects of cancer: an epidemiological approach. J Steroid Biochem Mol Biol. 1991;40(1-3):15–19. doi: 10.1016/0960-0760(91)90161-w. [DOI] [PubMed] [Google Scholar]
  11. Evans D. J., Hoffmann R. G., Kalkhoff R. K., Kissebah A. H. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab. 1983 Aug;57(2):304–310. doi: 10.1210/jcem-57-2-304. [DOI] [PubMed] [Google Scholar]
  12. Folsom A. R., Kaye S. A., Prineas R. J., Potter J. D., Gapstur S. M., Wallace R. B. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol. 1990 May;131(5):794–803. doi: 10.1093/oxfordjournals.aje.a115570. [DOI] [PubMed] [Google Scholar]
  13. Kaleko M., Rutter W. J., Miller A. D. Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol. 1990 Feb;10(2):464–473. doi: 10.1128/mcb.10.2.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kampert J. B., Whittemore A. S., Paffenbarger R. S., Jr Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk. Am J Epidemiol. 1988 Nov;128(5):962–979. doi: 10.1093/oxfordjournals.aje.a115070. [DOI] [PubMed] [Google Scholar]
  15. Kirschner M. A., Samojlik E., Drejka M., Szmal E., Schneider G., Ertel N. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab. 1990 Feb;70(2):473–479. doi: 10.1210/jcem-70-2-473. [DOI] [PubMed] [Google Scholar]
  16. Kissebah A. H., Peiris A. N. Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev. 1989 Mar;5(2):83–109. doi: 10.1002/dmr.5610050202. [DOI] [PubMed] [Google Scholar]
  17. Kodama M., Kodama T., Miura S., Yoshida M. Nutrition and breast cancer risk in Japan. Anticancer Res. 1991 Mar-Apr;11(2):745–754. [PubMed] [Google Scholar]
  18. Lapidus L., Helgesson O., Merck C., Björntorp P. Adipose tissue distribution and female carcinomas. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Int J Obes. 1988;12(4):361–368. [PubMed] [Google Scholar]
  19. London S. J., Colditz G. A., Stampfer M. J., Willett W. C., Rosner B., Speizer F. E. Prospective study of relative weight, height, and risk of breast cancer. JAMA. 1989 Nov 24;262(20):2853–2858. [PubMed] [Google Scholar]
  20. Macaulay V. M. Insulin-like growth factors and cancer. Br J Cancer. 1992 Mar;65(3):311–320. doi: 10.1038/bjc.1992.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McGuire W. L., Jr, Jackson J. G., Figueroa J. A., Shimasaki S., Powell D. R., Yee D. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J Natl Cancer Inst. 1992 Sep 2;84(17):1336–1341. doi: 10.1093/jnci/84.17.1336. [DOI] [PubMed] [Google Scholar]
  22. Nenci I., Marchetti E., Querzoli P. Commentary on human mammary preneoplasia. The estrogen receptor-promotion hypothesis. J Steroid Biochem. 1988;30(1-6):105–106. doi: 10.1016/0022-4731(88)90082-9. [DOI] [PubMed] [Google Scholar]
  23. Nielsen M., Thomsen J. L., Primdahl S., Dyreborg U., Andersen J. A. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987 Dec;56(6):814–819. doi: 10.1038/bjc.1987.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Petrek J. A., Peters M., Cirrincione C., Rhodes D., Bajorunas D. Is body fat topography a risk factor for breast cancer? Ann Intern Med. 1993 Mar 1;118(5):356–362. doi: 10.7326/0003-4819-118-5-199303010-00006. [DOI] [PubMed] [Google Scholar]
  25. Peyrat J. P., Bonneterre J., Beuscart R., Djiane J., Demaille A. Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res. 1988 Nov 15;48(22):6429–6433. [PubMed] [Google Scholar]
  26. Peyrat J. P., Bonneterre J., Hecquet B., Vennin P., Louchez M. M., Fournier C., Lefebvre J., Demaille A. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer. 1993;29A(4):492–497. doi: 10.1016/s0959-8049(05)80137-6. [DOI] [PubMed] [Google Scholar]
  27. Preziosi P., Barrett-Connor E., Papoz L., Roger M., Saint-Paul M., Nahoul K., Simon D. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the telecom study. J Clin Endocrinol Metab. 1993 Feb;76(2):283–287. doi: 10.1210/jcem.76.2.8432770. [DOI] [PubMed] [Google Scholar]
  28. Rochefort H., Garcia M. The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther. 1983;23(2):193–216. doi: 10.1016/0163-7258(83)90013-x. [DOI] [PubMed] [Google Scholar]
  29. Schapira D. V., Kumar N. B., Lyman G. H., Cox C. E. Abdominal obesity and breast cancer risk. Ann Intern Med. 1990 Feb 1;112(3):182–186. doi: 10.7326/0003-4819-112-3-182. [DOI] [PubMed] [Google Scholar]
  30. Schapira D. V., Kumar N. B., Lyman G. H. Obesity, body fat distribution, and sex hormones in breast cancer patients. Cancer. 1991 Apr 15;67(8):2215–2218. doi: 10.1002/1097-0142(19910415)67:8<2215::aid-cncr2820670836>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  31. Secreto G., Toniolo P., Berrino F., Recchione C., Cavalleri A., Pisani P., Totis A., Fariselli G., Di Pietro S. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res. 1991 May 15;51(10):2572–2576. [PubMed] [Google Scholar]
  32. Secreto G., Toniolo P., Pisani P., Recchione C., Cavalleri A., Fariselli G., Totis A., Di Pietro S., Berrino F. Androgens and breast cancer in premenopausal women. Cancer Res. 1989 Jan 15;49(2):471–476. [PubMed] [Google Scholar]
  33. Sellers T. A., Kushi L. H., Potter J. D., Kaye S. A., Nelson C. L., McGovern P. G., Folsom A. R. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med. 1992 May 14;326(20):1323–1329. doi: 10.1056/NEJM199205143262004. [DOI] [PubMed] [Google Scholar]
  34. Simon W. E., Albrecht M., Trams G., Dietel M., Hölzel F. In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin. J Natl Cancer Inst. 1984 Aug;73(2):313–321. doi: 10.1093/jnci/73.2.313. [DOI] [PubMed] [Google Scholar]
  35. Sims E. A. Destiny rides again as twins overeat. N Engl J Med. 1990 May 24;322(21):1522–1524. doi: 10.1056/NEJM199005243222109. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES